Psoriasis and cardiovascular disease: the elusive link

被引:43
|
作者
Manolis, Antonis A. [1 ]
Manolis, Theodora A. [2 ]
Melita, Helen [3 ]
Manolis, Antonis S. [4 ]
机构
[1] Univ Patras, Sch Med, Patras, Greece
[2] Zakynthos Hosp, Zakynthos, Greece
[3] Onassis Cardiac Surg Ctr, Athens, Greece
[4] Athens Univ, Sch Med, Dept Cardiol 3, Vas Sofias 114, GR-11527 Athens, Greece
关键词
Psoriasis; psoriatic arthritis; cardiovascular disease; coronary artery disease; myocardial infarction; metabolic syndrome; hypertension; dyslipidemia; SYSTEMIC ANTIINFLAMMATORY DRUGS; MYOCARDIAL-INFARCTION RISK; FACTOR INHIBITOR THERAPY; RHEUMATOID-ARTHRITIS; PLAQUE PSORIASIS; VASCULAR INFLAMMATION; NATIONAL-PSORIASIS; METABOLIC SYNDROME; CORONARY-ARTERY; VENOUS THROMBOEMBOLISM;
D O I
10.1080/08830185.2018.1539084
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Psoriasis, an autoimmune inflammatory disease, with its most common coexisting condition, psoriatic arthritis, seem to be more than just a local skin or joint disease, as evidence has accumulated over the years that it is associated with cardiovascular disease (CVD), which may confer an increased cardiovascular event and death rate. The data come mostly from observational studies and meta-analyses and indicate a potential pathogenetic link between these two systemic diseases, however definite proof of this detrimental relationship awaits further prospective studies. Newer anti-psoriatic biologic therapies seem to confer a cardiovascular benefit, but this needs future randomized controlled studies to confirm. All these intricate issues of a potential link between psoriasis and CVD are discussed and elaborated in this overview, in an attempt to shed further light on pivotal aspects of the association between psoriasis and CVD.
引用
收藏
页码:33 / 54
页数:22
相关论文
共 50 条
  • [1] Psoriasis and Cardiovascular Disease
    Shahwan, Kathryn T.
    Kimball, Alexa B.
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (06) : 1227 - +
  • [2] Psoriasis and cardiovascular disease
    Vena, Gino A.
    Vestita, Michelangelo
    Cassano, Nicoletta
    DERMATOLOGIC THERAPY, 2010, 23 (02) : 144 - 151
  • [3] Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis
    Lockshin, Benjamin
    Balagula, Yevgeniy
    Merola, Joseph F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (02) : 345 - 352
  • [4] Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment
    Hu, Stephen Chu-Sung
    Lan, Cheng-Che E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [5] Bioinformatics and Systems Biology Approach to Identify the Pathogenetic Link Between Psoriasis and Cardiovascular Disease
    Shi, Liping
    Du, Xiaoqing
    Li, Jing
    Zhang, Guoqiang
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 2283 - 2295
  • [6] Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
    Tobin, Anne-Marie
    Veale, Douglas J.
    Fitzgerald, Oliver
    Rogers, Sarah
    Collins, Paul
    O'Shea, Donal
    Kirby, Brian
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1386 - 1394
  • [7] Psoriasis and Cardiovascular Disease
    Torres, Tiago
    Sales, Rita
    Vasconcelos, Carlos
    Selores, Manuela
    ACTA MEDICA PORTUGUESA, 2013, 26 (05): : 601 - 607
  • [8] Management of cardiovascular disease in patients with psoriasis
    Egeberg, Alexander
    Skov, Lone
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (11) : 1509 - 1516
  • [9] Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community
    Menter, A.
    Griffiths, C. E. M.
    Tebbey, P. W.
    Horn, E. J.
    Sterry, W.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (12) : 1371 - 1377
  • [10] Cardiovascular Risk in Psoriasis: Current State of the Art
    Dattilo, Giuseppe
    Borgia, Francesco
    Guarneri, Claudio
    Casale, Matteo
    Bitto, Roberto
    Morabito, Claudia
    Signorelli, Salvatore
    Katsiki, Niki
    Cannavo, Serafinello P.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (01) : 85 - 91